These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1331 related articles for article (PubMed ID: 15286009)
21. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus. Moura CG; Mangueira CL; Cruz LA; Cruz CM Nephron Clin Pract; 2011; 118(4):c355-60. PubMed ID: 21325866 [TBL] [Abstract][Full Text] [Related]
22. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus. Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156 [TBL] [Abstract][Full Text] [Related]
23. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab]. Tsanyan ME; Torgashina AV; Aleksandrova EN; Soloviev SK; Nasonov EL Ter Arkh; 2013; 85(5):53-9. PubMed ID: 23819340 [TBL] [Abstract][Full Text] [Related]
24. Complement component c1q and anti-c1q antibodies in theory and in clinical practice. Potlukova E; Kralikova P Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591 [TBL] [Abstract][Full Text] [Related]
25. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria. Gunnarsson I; Sundelin B; Heimbürger M; Forslid J; van Vollenhoven R; Lundberg I; Jacobson SH J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009 [TBL] [Abstract][Full Text] [Related]
26. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Mok CC; Ho LY; Leung HW; Wong LG Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493 [TBL] [Abstract][Full Text] [Related]
27. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis. Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491 [TBL] [Abstract][Full Text] [Related]
28. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis. Yin Y; Wu X; Shan G; Zhang X Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies. Gutiérrez-Adrianzén OA; Koutouzov S; Mota RM; das Chagas Medeiros MM; Bach JF; de Holanda Campos H J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863 [TBL] [Abstract][Full Text] [Related]
32. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384 [TBL] [Abstract][Full Text] [Related]
34. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions. Tan Y; Yu F; Yang H; Chen M; Fang Q; Zhao MH Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001 [TBL] [Abstract][Full Text] [Related]
35. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis. Elshweikh SA; Elkhouly RM; Shaalan MM; Shorbagy SH Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352 [TBL] [Abstract][Full Text] [Related]
37. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease. Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860 [TBL] [Abstract][Full Text] [Related]
38. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity. Emad G; Al-Barshomy SM Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906 [TBL] [Abstract][Full Text] [Related]
39. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies. Pradhan VD; Patwardhan MM; Ghosh K Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543 [TBL] [Abstract][Full Text] [Related]
40. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus. Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]